Search

Your search keyword '"Kondili, L."' showing total 21 results

Search Constraints

Start Over You searched for: Author "Kondili, L." Remove constraint Author: "Kondili, L." Topic hepatitis c Remove constraint Topic: hepatitis c
21 results on '"Kondili, L."'

Search Results

1. Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a hemodialysis center.

2. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population.

3. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

4. The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case-control study in Albania.

5. Genotyping HCV isolates from Italy by type-specific PCR assay in the core region.

6. High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease.

7. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.

8. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

9. Optimization of hepatitis C virus screening strategies by birth cohort in Italy

10. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

11. Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort

12. L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

13. Modeling cost-effectiveness and health gains of a 'universal' versus 'prioritized' hepatitis C virus treatment policy in a real-life cohort

14. Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy.

15. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

16. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?

17. A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort

18. Global prevalence and genotype distribution of hepatitis C virus infection in 2015:a modelling study

19. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

20. Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort

21. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

Catalog

Books, media, physical & digital resources